http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0463636-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3899a93c972ce60b070fca823112248 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D337-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D337-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D327-02 |
| filingDate | 1985-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ece62e11c30c8e1cc5f02490577237dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d3fafab8beb2008d35f3d624199d2e0 |
| publicationDate | 1992-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0463636-A2 |
| titleOfInvention | Cardiovascular composition |
| abstract | A cardiovascular composition is disclosed which comprises a dibenzo-thiepin compound having the formulan n wherein:n X is a C₁-C₄ hydrocarbon group, optionally containing O, N or CO; Z is S, SO, SO₂, CO, CR⁴R⁵ wherein R⁴ and R⁵ taken together form the group =O or =CHR⁶ wherein R⁶ is hydrogen or phenyl; R¹ is, e.g., 5-tetrazolyl, 5-tetrazolylmethyl, nandn wherein m is an integer of from 0 to 4 and R⁷ is, e.g., hydroxy or loweralkoxy; R² and R³ can each independently be hydrogen, halogen (F, Cl, Br or I), nitro, loweralkyl, amino, N-loweralkylamino, N,N-diloweralkylamino, loweralkanoyl, hydroxy, loweralkoxy, lower acyloxy, loweralkylthio, trifluoromethylthio, loweralkylsulfinyl, loweralkylsulfonyl, trifluoromethyl, or R² and R³, when bonded to adjacent carbon atoms, can be joined to form a 5- or 6-membered hydrocarbon ring which can optionally contain a double bond, a carbonyl group, or a hydroxyl group; or na pharmaceutically acceptable salt thereof and an angiotensin converting enzyme (ACE) inhibitor. These compositions represent a novel therapeutic approach to thromboembolic diseases in man. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1087775-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1087775-A1 |
| priorityDate | 1984-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 368.